![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/00 | (2006.01) |
A61K 31/135 | (2006.01) | ||
A61K 31/138 | (2006.01) | ||
A61K 31/423 | (2006.01) | ||
A61K 31/4525 | (2006.01) | ||
A61K 31/485 | (2006.01) | ||
A61K 31/55 | (2006.01) | ||
A61K 31/551 | (2006.01) | ||
A61K 31/7048 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 3/10 | (2006.01) |
(11) | Number of the document | 2135603 |
(13) | Kind of document | T |
(96) | European patent application number | 09172666.1 |
Date of filing the European patent application | 2006-11-20 | |
(97) | Date of publication of the European application | 2009-12-23 |
(45) | Date of publication and mention of the grant of the patent | 2013-01-02 |
(46) | Date of publication of the claims translation | 2013-03-04 |
(30) | Number | Date | Country code |
738893 P | 2005-11-22 | US | |
759117 P | 2006-01-12 | US |
(72) |
Cowley, Michael A., US
Mckinney, Anthony A., US
Tollefson, Gary, US
|
(73) |
Orexigen Therapeutics, Inc.,
3344 North Torrey Pines Court, Suite 200, La Jolla, CA 92037,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Kompozicijos ir būdai, skirti jautrumo insulinui padidinimui |
Compositions and methods for increasing insulin sensitivity |
Payment date | Validity (years) | Amount | |
2024-11-11 | 19 | 347.00 EUR |
2025-11-20 |